DS-1040b + Clopidogrel
Phase 1Completed 0 watching 0 views this week๐ค Quiet
33
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug Interaction
Conditions
Drug Interaction
Trial Timeline
Dec 1, 2015 โ Mar 1, 2016
NCT ID
NCT02560688About DS-1040b + Clopidogrel
DS-1040b + Clopidogrel is a phase 1 stage product being developed by Daiichi Sankyo for Drug Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT02560688. Target conditions include Drug Interaction.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02560688 | Phase 1 | Completed |
Competing Products
20 competing products in Drug Interaction